A results-driven Chief Financial Officer, I draw upon more than three decades of finance and business acumen to drive superior company performance. My expertise lies in cultivating exceptional finance teams and harnessing their capabilities to support our business partners across the organization in achieving and surpassing collective business objectives.Collaborating closely with executive leadership and their respective teams, I am instrumental in formulating and executing strategic, sustainable mid- and long-term business plans. I possess a keen ability to adapt and refine these plans as necessary to optimize outcomes, employing investment strategies with clear, quantifiable metrics to underpin our strategic initiatives.Central to my leadership approach is the cultivation of a culture marked by collaboration, robust business partnerships, and effective communication both within my team and across the broader organization. I prioritize the solicitation of diverse perspectives and insights to facilitate prompt and decisive decision-making, setting a precedent of accountability and fostering a continuous learning environment wherein setbacks serve as opportunities for growth and organizational strengthening.I am deeply committed to fostering a positive work environment conducive to individual growth and collective prosperity, wherein business objectives, expectations, and achievements are transparently communicated and celebrated.Drawing upon my extensive international experience, as well as a proven record in product launches and mergers and acquisitions (M&A), I consistently deliver tangible, impactful results that drive sustainable business growth and success.
-
Executive Vice President And Chief Financial Officer For Smpah And SunovionSumitomo Pharma America Holdings, Inc. 2020 - 2023Marlborough, Massachusetts, UsServed as CFO for nine years at Sumitomo Pharma America (SMPAH) and Sunovion (a subsidiary of SMPAH) with dual reporting to the CEOs of both companies. Advisor to the audit committee of multiple SMPAH companies. Worked closely with the CFOs of four North America affiliates, providing them with shared-services supports in areas such as technical accounting and reporting, financial operations, corporate IT, insurance, and tax -
Senior Vice President And Chief Financial OfficerSunovion Pharmaceuticals 2014 - 2020Marlborough, Ma, Us -
Vice President And ControllerSunovion Pharmaceuticals 2010 - 2014Marlborough, Ma, UsLed the finance integration following SMP-Japan’s acquisition of Sepracor (see position below), acting as a liaison between US and Japan management and finance teams. Reported to the Sunovion CFO and supervised seven direct reports. -
Executive Director And Assistant ControllerSepracor Inc 2005 - 2010Responsibilities included oversight of all corporate accounting matters as well as SEC and internal financial reporting while serving as primary contact for the external audit team. -
Director Of AccountingSepracor Inc 2004 - 2005 -
Corporate ControllerFirepond Inc 2000 - 2003
-
Accounting ManagerAllegro Microsystems 1996 - 2000Manchester, Nh, Us -
Supervisory Audit SeniorErnst & Young 1992 - 1996London, Gb
Steve Freeman Education Details
-
Clark UniversityMaster Of Business Administration -
Worcester State UniversityGeneral
Frequently Asked Questions about Steve Freeman
What is Steve Freeman's role at the current company?
Steve Freeman's current role is Chief Financial Officer | Strategic & Collaborative Life Sciences Leader | Pharmaceuticals | Transformational Finance Executive | M&A | Product Launch | Board Ready.
What schools did Steve Freeman attend?
Steve Freeman attended Clark University, Worcester State University.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial